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Abstract
Background: Plasmodium falciparum can be detected by microscopy, histidine-rich-protein-2 (HRP2) capture test or
PCR but the respective clinical relevance of the thereby diagnosed infections in pregnant women is not well established.
Methods: In a cross-sectional, year-round study among 839 delivering women in Agogo, Ghana, P. falciparum was
screened for in both, peripheral and placental blood samples, and associations with maternal anaemia, low birth weight
(LBW) and preterm delivery (PD) were analysed.
Results: In peripheral blood, P. falciparum was observed in 19%, 34%, and 53% by microscopy, HRP2 test, and PCR,
respectively. For placental samples, these figures were 35%, 41%, and 59%. Irrespective of diagnostic tool, P. falciparum
infection increased the risk of anaemia. Positive peripheral blood results of microscopy and PCR were not associated
with LBW or PD. In contrast, the HRP2 test performed well in identifying women at increased risk of poor pregnancy
outcome, particularly in case of a negative peripheral blood film. Adjusting for age, parity, and antenatal visits, placental
HRP2 was the only marker of infection associated with LBW (adjusted odds ratio (aOR), 1.5 (95%CI, 1.0–2.2)) and, at
borderline statistical significance, PD (aOR, 1.4 (1.0–2.1)) in addition to anaemia (aOR, 2.3 (1.7–3.2)). Likewise, HRP2 in
peripheral blood of seemingly aparasitaemic women was associated with PD (aOR, 1.7 (1.0–2.7)) and anaemia (aOR, 2.1
(1.4–3.2)).
Conclusion: Peripheral blood film microscopy not only underestimates placental malaria. In this highly endemic setting,
it also fails to identify malaria as a cause of foetal impairment. Sub-microscopic infections detected by a HRP2 test in
seemingly aparasitaemic women increase the risks of anaemia and PD. These findings indicate that the burden of malaria
in pregnancy may be even larger than thought and accentuate the need for effective anti-malarial interventions in
pregnancy.
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Malaria in pregnancy continues to be a major public
health problem in sub-Saharan Africa. Pregnant women
are a specific risk group for Plasmodium falciparum infec-
tion, malaria and related consequences [1]. This increased
risk is partially due to physiological alterations of immu-
nity. Moreover, in pregnancy and by virtue of specific
expression variants of the P. falciparum Erythrocyte Mem-
brane Protein-1, parasite strains adhere to the syncytiotro-
phoblast, i.e. the surface lining the placental intervillous
space. As immune recognition of and, thus, response to
these parasites are low in primigravidae susceptibility and
clinical manifestation are increased. With subsequent
pregnancies, protective immune mechanisms gradually
develop and expand, and manifestation of infection
declines [2-4].
The placental sequestration of P. falciparum results in the
accumulation of parasitized erythrocytes in the intervil-
lous space, infiltration by inflammatory cells and release
of pro-inflammatory mediators [5]. Clinical conse-
quences of placental malaria, i.e. parasites and/or malaria
pigment (haemozoin) present in placental blood, com-
prise maternal anaemia, low birth weight (LBW), preterm
delivery (PD), and, consequently, increased perinatal and
infant mortality [1,6-9]. In highly endemic regions,
infected women are commonly asymptomatic [10].
Because of placental sequestration, peripheral blood film
microscopy grossly underestimates the prevalence of pla-
cental malaria [11,12].
As with malaria in children, the prevalence and manifes-
tation of malaria in pregnancy varies with transmission
intensity, access to treatment, coverage and quality of
antenatal services, and drug resistance, among others. The
role of sub-microscopic P. falciparum infections, i.e. below
the threshold of peripheral blood microscopy, is not well
established [10,11,13-16]. The present study aimed at
assessing prevalence and clinical consequences of P. falci-
parum infections detected in peripheral and placental
blood by microscopy, histidine-rich-protein-2 (HRP2)
capture test, and PCR among women delivering at a dis-
trict hospital in rural southern Ghana. The performances
of the diagnostic tests in a subset of 596 women have been
reported previously [12]. Here, results from all 839 live-
singleton deliveries are reported, focusing on the clinical
manifestation of malaria in pregnancy.
Methods
Agogo is a community of some 30,000 inhabitants
located in the forested hills of Ashanti Akim North Dis-
trict. Subsistence farming, trade and mining are the main
income sources in that region, and malaria is hyper- to
holoenedemic [17]. In 1998, P. falciparum among women
attending antenatal care at Agogo District Hospital was
detected in 32% and 63% by microscopy and PCR assays
of peripheral blood samples, respectively [10]. Then and
at the time of study, chemoprophylaxis with pyrimeth-
amine (PYR) was recommended in pregnancy; yet, P. fal-
ciparum mutations conferring PYR resistance are frequent
in the area [18]. From January 2000 to January 2001,
women attending Agogo Hospital for delivery were asked
to participate in the present study and recruited after
informed written consent was obtained. The study proto-
col was reviewed and approved by the Committee on
Human Research Publications and Ethics, School of Med-
ical Sciences, University of Science and Technology,
Kumasi.
All women were clinically examined, socio-demographic
data were documented, and venous peripheral blood col-
lected into EDTA. Fever was defined as an axillary temper-
ature >37.4°C. Following expulsion and after a small
incision had been made into the maternal surface of the
placenta, blood from the intervillous space was collected
with a syringe containing EDTA. P. falciparum was
screened for in both placental and peripheral blood sam-
ples by microscopy, HRP2 test, and PCR: malaria parasites
were counted microscopically on Giemsa-stained thick
blood films per 500 white blood cells for peripheral sam-
ples and per 100 high-power fields for placental samples
in which the presence of leukocyte-associated haemozoin
was also recorded. Based on placental thick blood film
microscopy, the stage of placental infection was catego-
rized as [5] early, only parasites visible; late, both parasites
and pigment present; resolved, only pigment visible; and
none, neither parasites nor haemozoin present. HRP2 was
detected by rapid immuno-chromatographic tests (ICT
Malaria P.f/P.v, Becton Dickinson, Germany). Following
DNA extraction (QIAmp, Qiagen, Germany), nested P.
falciparum-specific PCR assays were performed [19].
Plasma concentrations of chloroquine (CQ) and PYR
were measured by ELISA assays [20] with limits of detec-
tion of 5 ng/mL and 10 ng/mL, respectively. Haemo-
globin (Hb) was measured by a HemoCue photometer
(Ångelholm, Sweden) and anaemia defined as Hb <11 g/
dL. Crude birth weight and gestational age were assessed
within 24 hours after delivery. LBW was defined as a birth
weight <2500 g and PD as gestational age <37 weeks
applying the Finnström score [21].
Geometric mean parasite densities (GMPDs) and 95%
confidence intervals (95%CIs) were calculated. Continu-
ous variables were compared between groups by t-test,
analysis of variance, Mann-Whitney U test, and Kruskal-
Wallis test as applicable. Associations between P. falci-
parum infection and anaemia, LBW, and PD were identi-
fied by χ2 test, odds ratios (ORs) calculated, and adjusted
for confounders by logistic regression models.Page 2 of 10
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From January 2000 to January 2001, 889 delivering and
consenting women were recruited and 922 babies were
born (859 singles; 30 twin pairs, one set of triplets), of
whom 22 (2.4%) were born dead or died within 24 hours
after delivery. The characteristics of the 839 women with
live-singleton deliveries are shown in Table 1. About half
of the women originated from Agogo and about half had
previously attended ≤3 antenatal care visits. Parity was
strongly associated with LBW and PD, rates being more
than double in primiparae (each, 26%) than in multi-
parae (Table 1). Fever was rare (3%). PYR in plasma was
detected in 35% (median, 46 ng/mL; range, 11–1000)
and CQ in 22% (median, 31 ng/mL; range, 6–1248).
Detection and prevalence of Plasmodium falciparum
In all 839 peripheral samples, P. falciparum was detected
in 19.0%, 34.1%, and 52.9% by microscopy, HRP2 test,
and PCR, respectively. For placental samples, these figures
were 34.9%, 40.8%, and 59.4%; placental haemozoin was
seen in 30.9%. As reported before [12], sensitivity of
peripheral blood film microscopy in detecting placental
infection was poor. It was 50% (95%CI, 44–59) and 32%
(56–63) taking the results of placental microscopy and
PCR assays, respectively, as reference (specificities, 98%
(96–99) and 100% (99–100)). For HRP2 tests on periph-
eral blood samples, these sensitivities were 78% (73–82;
specificity, 89% (86–92)) and 56% (51–60; specificity,
98% (95–99)). PCR assays on peripheral samples
achieved a sensitivity of 97% (94–99; specificity, 71%
(69–75)) for microscopically confirmed placental parasi-
taemia and of 87% (83–89; specificity, 96% (93–98))
with PCR-proven placental infection as reference. Irre-
spective of diagnostic technique, P. falciparum declined in
prevalence with parity as did placental parasite density
(Table 2). Also, the presence of haemozoin decreased with
parity and, consequently, late infections predominated in
primiparae and early infections in multiparae (Table 2).
Non-falciparum species were rare (six Plasmodium malar-
iae, five Plasmodium ovale) and not related to parity.
Factors influencing the presence of placental malaria
Placental haemozoin was the clinically most relevant
marker of infection and factors influencing its presence
were analysed. In multivariate analysis, primiparity, low
age, and delivery in the rainy season were independently
associated with haemozoin (Table 3). In women with >3
antenatal care visits, haemozoin was somewhat less com-
mon (28.2%, 121/429) than in women with fewer visits
(33.7%, 132/392; P = 0.09). PYR in plasma was associated
Table 1: Characteristics of 839 women with live singleton deliveries
Parameter All Primiparae Parae II & III Multiparae (>III) P
No. (%) 839 (100) 304/832 (36.5) 305/832 (36.7) 223/832 (26.8)
Age (years; median, range; n = 827) 25 (15–47) 21 (15–36) 25 (18–40)* 33 (22–47)* < 0.0001
Residence in Agogo (%, No.) 48.9 (410) 48.7 (148/304) 54.8 (167/305) 41.3 (92/223) 0.009
Proportion without school degree (%, No.) 15.4 (128/829) 8.6 (26/302) 14.6 (44/302)* 26.0 (57/219)* < 0.0001
Axillary temperature (°C; mean ± SD; n = 826) 36.4 ± 0.5 36.5 ± 0.6 36.4 ± 0.5 36.4 ± 0.5 0.32
Fever (%, No.) 2.8 (23/826) 4.0 (12/300) 1.7 (5/302) 2.7 (6/129) 0.22
Haemoglobin (g/dL; median; range) 11.5 (4.6–16.8) 11.4 (4.6–16.4) 11.6 (5.8–16.8) 11.5 (4.7–15.6) 0.28
Anaemia (haemoglobin <11 g/dL) 35.2 (295) 38.5 (117/304) 32.5 (99/305) 35.0 (78/223) 0.30
No. of previous ANC visits (median, range, n = 821) 4 (0–12) 3 (0–11) 4 (0–12)* 4 (0–10) 0.01
Proportion with ≤3 ANC visits (%, No.) 47.7 (392/821) 52.5 (156/297) 43.1 (129/299)* 47.9 (105/219) 0.07
Caesarean section (%, No.) 22.1 (185) 21.7 (66/304) 19.0 (58/305) 26.5 (59/223) 0.12
Birth weight (g; median, range; n = 838) 2950 (1280–4500) 2785 (1280–4000) 3000 (1600–4250)* 3100 (1500–4500)* <0.0001
Gestational age (weeks; median, range; n = 831) 38.4 (20.0–43.1) 38.4 (20.0–43.1) 39.0 (32.0–43.1)* 39.4 (27.0–42.1)* 0.0001
Low birth weight (LBW) 16.0 (134/837) 26.0 (79/304) 10.9 (33/304)* 9.4 (21/223)* < 0.0001
Preterm delivery 18.8 (156/831) 26.3 (80/304) 16.0 (48/300)* 12.2 (27/221)* < 0.0001
Proportion with chloroquine in plasma (%, No.) 22.4 (182/821) 27.9 (83/298) 19.1 (57/299)* 19.4 (42/217)* 0.02
Proportion with pyrimethamine in plasma (%, No.) 35.0 (287/821) 35.6 (106/298) 33.8 (101/299) 35.9 (78/217) 0.85
*, difference to primiparae, P < 0.05; ANC, antenatal carePage 3 of 10
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Table 2: Prevalence of Plasmodium falciparum in 832 delivering women according to parity
Parameter Prevalence of Plasmodium falciparum (%) P
Primiparae Parae II & III Multiparae
No. 304 305 223
Peripheral blood
Diagnosic mean
Microscopy 27.0 16.4* 11.7* < 0.0001
HRP2 test 45.4 30.5* 23.8* < 0.0001
PCR 59.2 52.1 46.2* 0.01
GMPD (µL, 95%CI) 740 (481–1137) 343 (189–623)* 593 (263–1336) 0.12
Placental blood
Diagnostic mean
Microscopy 46.1 33.1* 22.0* < 0.0001
Haemozoin 42.4 29.8* 16.6* < 0.0001
HRP2 test 50.7 37.4* 32.3* < 0.0001
PCR 65.1 59.7 52.0* 0.01
GMPD (/HPF; 95%CI) 1.2 (0.8–1.8) 0.6 (0.4–1.1) 0.4 (0.2–0.7)* 0.01
Stage of infection
None 47.4 57.7* 70.9*
Resolved 6.6 9.2 7.2
Late 35.9 20.7* 9.4*
Early 10.2 12.5 12.6 < 0.0001
HRP2, histidine-rich-protein 2; GMPD, geometric mean parasite density; 95%CI, 95% confidence interval; HPF, high power field; *, difference to 
primiparae, P < 0.05
Table 3: Risk factors of placental haemozoin
Factor Haemozoin detected (%, fraction) Univariate analysis Multivariate analysis
OR (95%CI) P OR (95%CI) P
Parity
>1 24.2 (128/528) 1 1
1 42.4 (129/304) 2.3 (1.7–3.2) < 0.0001 1.5 (1.0–2.2) 0.04
Age-group (years)
>30 17.4 (33/190) 1 1
26–30 27.0 (57/211) 1.8 (1.1–2.9) 0.02 1.7 (1.0–2.8) 0.04
21–25 33.9 (82/242) 2.4 (1.5–4.0) 0.0001 2.1 (1.3–3.5) 0.003
≤20 45.7 (84/184) 4.0 (2.4–6.6) <0.0001 3.0 (1.7–5.2) 0.0002
Season
Dry 27.1 (109/402) 1 1
Rainy* 34.3 (150/437) 1.4 (1.0–1.9) 0.02 1.4 (1.1–2.0) 0.02
OR, odds ratio: 95%CI, 95% confidence interval; *, rainy season, May-October
Malaria Journal 2006, 5:119 http://www.malariajournal.com/content/5/1/119with a slight reduction in the prevalence of haemozoin
only (27.9%, 80/287 vs. 32.4%, 173/534; P = 0.18). In
primiparae, this difference was pronounced and statisti-
cally significant (31.1%, 33/106 vs. 47.9%, 92/192; P =
0.005).
Association between diagnosis of malaria and its clinical 
manifestation
Irrespective of diagnostic tool, P. falciparum infection
increased the risk of maternal anaemia (Table 4). A posi-
tive peripheral blood film or a positive PCR result were
neither associated with LBW nor with PD. In peripheral
blood samples, the HRP2 test best discriminated women
with and without malaria-associated adverse foetal out-
come (Table 4). Importantly, in women with a negative
peripheral blood film, a positive HRP2 test indicated risk
increases of 71%, 79%, and 114% for LBW, PD, and anae-
mia, respectively. A positive PCR signal in this sub-group
was associated only with anaemia. Further stratification
revealed that in case of a positive peripheral result exclu-
sively by PCR (n = 160), the proportions of LBW (15%)
and PD (14%) were similar to the figures in de facto non-
infected women (n = 382; 14%, P = 0.7; and 17%, P =
0.4). Still, the prevalence of anaemia was increased (39%
vs. 25%, P = 0.002).
Peripheral blood parasite densities (GMPD, 558/µL;
95%CI, 404–772) correlated negatively with Hb (log10
parasite density, r = -0.18, P = 0.02) and gestational week
(r = -0.18, P = 0.03) but not with birth weight (r = -0.06;
P = 0.5). Placental parasite density (GMPD, 0.78/high
power field; 95%CI, 0.06–1.03) did not show such corre-
lations.
On the basis of placental sampling, again, microscopic
and PCR detection of parasitaemia were not associated
with LBW or PD whereas a positive HRP2 result was. Nev-
ertheless, haemozoin was the marker of infection most
strongly associated with all clinical consequences (Table
4). Likewise, late infections were found to be the most del-
eterious ones while patients with early infections clini-
cally were similar to non-infected women. Haemozoin
was also associated with the largest reduction in birth
weight (median, 2850 g (range, 1280–4160) vs. 3000 g
(1420–4500), P < 0.0001) which was smaller in case of a
positive HRP2 test (2880 g (1420–4160) vs. 3000 (1280–
4500), P = 0.0009) or a positive PCR result (2900 (1280–
4350) vs. 3000 g (1500–4500), P = 0.04), and smallest if
placental parasites were seen by microscopy (2900 g
(1280–4160) vs. 2970 g (1420–4500), P = 0.02). Like-
wise, any diagnosis of placental P. falciparum was associ-
ated with significantly reduced Hb levels, but the
reduction was largest in the presence of haemozoin
(median, 10.8 g/dL (range, 4.6–15.6) vs. 11.7 g/dL (4.7–
16.8), P < 0.0001). The week of gestation was not associ-
ated with infection, irrespective of diagnostic mean
applied (data not shown).
Adjusting the above associations between P. falciparum
infection and clinical manifestation for the confounders
age, parity, and number of antenatal care visits did not
substantially change the findings, however, statistical sig-
nificance in terms of LBW and PD was reduced (Table 5).
Discussion
Placental malaria is an important cause of both LBW and
PD, which, in turn, are major determinants of neonatal
and infant mortality [22-24]. Annually, up to 200,000
infant deaths are attributed to malaria in pregnancy [25].
However, malaria in pregnancy frequently lacks overt clin-
ical signs and its diagnosis is complicated by placental
parasite sequestration.
In the present study, the vast majority of P. falciparum-
infected delivering women were asymptomatic, and
microscopy of thick films from peripheral blood missed
more current infections than it detected. Roughly half of
the women with microscopically proven placental parasi-
taemia had a negative peripheral blood film. The observed
superior sensitivities of peripheral blood PCR or HRP2
assays are essentially in accord with previous reports
[11,14,26,27] and underscore that a negative peripheral
blood film in pregnant women in endemic areas is hardly
informative. In addition, the present study shows that in
contrast to peripheral blood microscopy and PCR, HRP2
detection indicates an increased risk of poor pregnancy
outcome and that sub-microscopic infections in preg-
nancy are associated with maternal and foetal morbidity.
Placental histology is considered the "gold standard" of
malaria diagnosis in pregnancy for epidemiological or
study purposes, however, due to limited technical exper-
tise it is rarely available in endemic areas. Examination of
thick films of blood samples obtained by placental inci-
sion is comparatively easier. As compared to histology,
sensitivity and specificity of this method have been
reported to be 76% and 99%, respectively, and thus to be
in the range of microscopy of blood films produced by
scraping the wall of the incision or by spinning down
erythrocyte pellets from biopsy washings [28]. The detec-
tion of haemozoin on placental thick blood films likely is
influenced by this difference in sensitivity and also
neglects pigment deposition in placental structures. Con-
sequently, staging placental infection based on placental
thick blood films findings [5] – although deduced from
the histological classification after Bulmer et al. [29] – is
not fully comparable to histology and needs further eval-
uation. Nevertheless, haemozoin may be considered a
"black box" in recording episodes of malaria in pregnancy
even though the time span during which pigment can bePage 5 of 10
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Table 4: Prevalences of low birth weight, preterm delivery, and maternal anaemia according to diagnosis of Plasmodium falciparum
Diagnostic tool No. Low birth weight Preterm delivery Anaemia
% OR (95%CI) P % OR (95%CI) P % OR (95%CI) P
Peripheral blood
Microscopy
Negative 680 15.8 18.4 32.9
Positive 159 17.0 1.1 (0.7–1.8) ns 20.3 1.1 (0.7–1.8) ns 44.7 1.6 (1.1–2.4) 0.005
HRP2 test
Negative 553 14.3 16.5 29.5
Positive 286 19.4 1.4 (1.0–2.1) 0.06 23.1 1.5 (1.1–2.2) 0.02 46.2 2.1 (1.5–2.8) <0.0001
PCR
Negative 395 14.2 17.9 25.6
Positive 444 17.6 1.3 (0.9–1.9) ns 19.6 1.1 (0.8–1.6) ns 43.7 2.3 (1.7–3.1) <0.0001
HRP2 test if microscopy negative
Negative 542 14.2 16.5 29.3
Positive 138 21.9 1.7 (1.0–2.8) 0.03 26.1 1.8 (1.1–2.9) 0.01 47.1 2.1 (1.4–3.2) <0.0001
PCR if microscopy negative
Negative 394 14.2 17.9 25.6
Positive 286 17.9 1.3 (0.9–2.0) ns 19.1 1.1 (0.7–1.6) ns 43.0 2.2 (1.6–3.1) <0.0001
Placental blood
Microscopy
Negative 546 14.3 17.7 28.8
Positive 293 19.2 1.4 (1.0–2.1) 0.07 20.8 1.2 (0.8–1.8) ns 47.1 2.2 (1.6–3.0) <0.0001
Haemozoin
Negative 580 13.6 16.5 27.8
Positive 259 21.3 1.7 (1.2–2.6) 0.005 23.9 1.6 (1.1–2.3) 0.01 51.7 2.8 (2.0–3.8) <0.0001
HRP2 test
Negative 497 12.9 16.0 27.0
Positive 342 20.5 1.8 (1.2–2.6) 0.003 22.8 1.6 (1.1–2.2) 0.01 47.1 2.4 (1.8–3.3) <0.0001
PCR
Negative 341 13.5 17.5 23.8
Positive 498 17.7 1.4 (0.9–2.1) ns 19.7 1.2 (0.8–1.7) ns 43.0 2.4 (1.8–3.3) <0.0001
Stage of infection
None 482 13.5 16.7 27.0
Resolved 64 20.3 1.6 (0.8–3.3) ns 25.0 1.7 (0.9–3.2) ns 42.2 2.0 (1.1–3.5) 0.01
Late 195 21.6 1.8 (1.1–2.8) 0.009 23.6 1.5 (1.0–2.4) 0.04 54.9 3.3 (2.3–4.7) <0.0001
Early 98 14.3 1.1 (0.6–2.1) ns 15.5 0.9 (0.5–1.7) ns 31.6 1.3 (0.8–2.1) ns
OR, odds ratio, 95%CI, 95% confidence interval; ns, not significant, P > 0.1
Malaria Journal 2006, 5:119 http://www.malariajournal.com/content/5/1/119found after resolved infection is unknown. In Thailand,
placental haemozoin was observed among women with
preceding malaria during the first trimester [30] but in
Malawi, haemozoin concentrations were not elevated in
women who had infections early in pregnancy [31]. For
clinical use, haemozoin detection is practically unhelpful
as it can be performed only at delivery, however, for epi-
demiological and intervention studies, it appears feasible
and cost-effective.
The sensitivities of the HRP2 test (78%) or PCR (97%) in
detecting microscopically proven placental parasitaemia
in peripheral blood were substantially higher than the one
of peripheral blood film microscopy (50%). Improving
performances of the peripheral blood tests with increasing
placental parasite density have been described previously
[12]. Because P. falciparum secretes HRP2, this protein can
be detected in peripheral blood despite placental seques-
tration. In the present study, the specificities of the HRP2
test and of PCR were rather low when placental parasitae-
mia was taken as the reference. However, this probably is
due to undetected parasites: when a positive placental
PCR result was set as reference, specificities of HRP2 test
and PCR on peripheral blood samples approached 100%.
Similarily, the few studies comparing histology to PCR
indicate a specificity of the latter of 100% [32,33]. Never-
theless, it should be kept in mind that PCR assays can
remain positive for some days after curative treatment
(and HRP2 tests for some weeks) [34,35].
Poor pregnancy outcome, e.g. LBW or PD, in this cross-
sectional study at delivery was neither associated with a
positive peripheral blood result of microscopy nor of
PCR. This may be explained by the low sensitivity of the
former, and the very high one of the latter. The HRP2 test
with in-between sensitivity appears to be a practical com-
promise between sensitivity on the one hand and detect-
ing clinically relevant infection on the other. Importantly,
in seemingly aparasitaemic women, i.e. in those with a
negative peripheral blood film, a positive HRP2 test was
associated with anaemia, LBW and PD. Infections
detected beyond that exclusively by PCR had no discerni-
ble effect on pregnancy outcome but were still associated
with reduced maternal Hb. Previous studies on that topic
produced conflicting results: in Ghana but not in Sudan,
Mozambique, and Cameroon, sub-microscopic periph-
eral blood infections as detected by PCR were associated
with low Hb levels or anaemia [10,13,15,16]. Similar to
the findings of the present study, P. falciparum as identi-
fied by peripheral blood microscopy or PCR in Burkina
Faso was not associated with LBW or birth weight whereas
the latter was reduced in case of a positive peripheral
blood HRP2 dipstick [14]. Women found to be P. falci-
parum positive by PCR exclusively exhibited no increased
risk of LBW in Malawi [11]. One study from Kenya
reported that malaria as assessed by peripheral blood film
was stronger associated with intrauterine growth retarda-
tion than were peripheral PCR or detection of circulating
parasite antigen [36]. Differing results in these studies
may be due to sample sizes, endemicity, and techniques
applied. Taken together, one conclusion could be that
PCR assays also detect low-level infections which produce
no major foetal impairment. However, this interpretation
needs caution as the course of sub-microscopic P. falci-
parum infection in pregnancy, e.g. abortive, chronic or
progressive, is unknown. Considering the common fluc-
Table 5: Adjusted risk estimates for low birth weight, preterm delivery, and maternal anaemia according to diagnosis of Plasmodium 
falciparum
Positive diagnosis Low birth weight Preterm delivery Anaemia
aOR (95%CI) P aOR (95%CI) P aOR (95%CI) P
Peripheral blood
Microscopy 0.9 (0.6–1.5) ns 1.1 (0.7–1.7) ns 1.6 (1.1–2.3) 0.01
HRP2 test 1.2 (0.8–1.8) ns 1.4 (0.9–2.0) ns 2.0 (1.5–2.7) <0.0001
PCR 1.1 (0.8–1.7) ns 1.1 (0.7–1.5) ns 2.1 (1.6–2.9) <0.0001
HRP2 test if microscopy negative 1.5 (0.9–2.5) ns 1.7 (1.0–2.7) 0.03 2.1 (1.4–3.2) 0.0002
PCR if microscopy negative 1.2 (0.8–1.9) ns 1.0 (0.7–1.6) ns 2.0 (1.4–2.8) <0.0001
Placental blood
Microscopy 1.1 (0.7–1.7) ns 1.1 (0.7–1.6) ns 2.2 (1.6–2.9) <0.0001
Haemozoin 1.3 (0.8–1.9) ns 1.3 (0.9–1.9) ns 2.8 (2.0–3.9) <0.0001
HRP2 test 1.5 (1.0–2.2) 0.04 1.4 (1.0–2.1) 0.055 2.3 (1.7–3.2) <0.0001
PCR 1.2 (0.8–1.9) ns 1.1 (0.8–1.6) ns 2.4 (1.7–3.3) <0.0001
Stage of infection
Resolved 1.5 (0.8–3.0) ns 1.5 (0.8–2.9) ns 2.0 (1.1–3.4) 0.02
Late 1.2 (0.8–1.9) ns 1.2 (0.8–1.9) ns 3.4 (2.3–4.9) <0.0001
Early 1.1 (0.6–2.1) ns 1.0 (0.5–1.8) ns 1.2 (0.8–2.0) ns
aOR, adjusted odds ratio, 95%CI, 95% confidence interval; ns, not significant, P > 0.1. Odds ratios are adjusted for age (years), parity (log10), and 
antenatal care (≤, > 3 visits).Page 7 of 10
(page number not for citation purposes)
Malaria Journal 2006, 5:119 http://www.malariajournal.com/content/5/1/119tuations of parasite density [37], the temporal pattern of
the manifestation of malaria in pregnancy [7] and the
results presented here any infection detected should be
considered potentially harmful (and treated). Even sub-
microscopic infections detected exclusively by PCR were
associated with maternal anaemia which may impair
physical performance and increase the risk of PD [38].
The detection of haemozoin and placental HRP2 to simi-
lar extents were univariately associated with anaemia,
LBW and PD but the reductions of Hb and birth weight
were most pronounced in women with placental pigment.
The association between placental haemozoin and LBW is
well documented, e.g. in Senegal [39]. In contrast, in
Malawi, haemozoin concentrations were neither associ-
ated with PD nor with intrauterine growth retardation
[31], and in Tanzania, the role of placental pigment in
LBW and PD waned when considering mononuclear pla-
cental infiltration and high peripheral parasite density,
respectively [8]. The latter authors argued that haemozoin
rather reflects the severity of a recent infection than having
direct detrimental effects on foetal growth. However,
haemozoin concentrations have been reported to corre-
late with the placental expression of tumour necrosis fac-
tor [40], and recent investigations indicate that pigment is
not inert but exhibits direct clinical effects [41].
After adjusting for age, parity, and antenatal visits, the risk
of maternal anaemia remained to be increased in the pres-
ence of P. falciparum, irrespective of diagnostic tool. How-
ever, in terms of placental diagnosis, only HRP2 was
associated with LBW and PD, the latter at borderline sta-
tistical significance. Also, seemingly aparasitaemic
women with HRP2 in peripheral blood exhibited an
increased risk of PD. Infection detected by microscopy or
PCR were not correlated with birth outcome. This unex-
pected but not uncommon finding [6,7,42] may reflect
the importance of the temporal pattern of infection [7]
and the greater contribution of various other factors to
adverse foetal outcome. For instance, HIV infection, mal-
nutrition, genetic traits, smoking, and a low socio-eco-
nomic status are risk factors for poor pregnancy outcome
[43-45] but these factors were either not assessed or were
rare. Recent data indicate a median HIV prevalence of
2.7% among antenatal care attendees in Ghana [46]. Still,
malaria may effect poor pregnancy outcome indirectly via
maternal anaemia [38,47].
The effects of antenatal care and of PYR in plasma were
modest in that infection was not consistently prevented
by either factor. Reasons for the limited impact of PYR
chemoprophylaxis likely include poor compliance (only
35% of the women had detectable PYR) and drug resist-
ance. Already in 1998, 81% and 36% of P. falciparum iso-
lated from pregnant women in Agogo exhibited a
dihydrofolate reductase resistance core mutation and the
high resistance triple mutation, respectively [18]. From
2005 on, intermittent preventive treatment (IPT) with sul-
fadoxine-pyrimethamine is operative at Agogo Hospital,
and results from a survey in pregnancy in 2006 are being
awaited. Optimistically, with extended antenatal services
and coverage, and IPT, a reduction in the burden of
malaria in pregnancy in this area should be achievable.
Conclusion
In conclusion, placental malaria commonly is missed by
standard microscopy of peripheral blood films. Whereas
positive results of PCR seem not to be related to poor
pregnancy outcome, detection of HRP2 is capable of iden-
tifying P. falciparum infections associated with maternal
and foetal morbidity. This is particularly true for women
with a negative peripheral blood film. These findings are
of importance for the implementation and evaluation of
preventive measures for pregnant women in endemic
areas and likely also for the assessment of response to
treatment. The incorporation of sensitive rapid test
devices such as HRP2 tests into antenatal services would
be desirable. So far, the costs of IPT with SP are lower than
the price of a dipstick of €1 ore more. However, cost-ben-
efit considerations may change once SP has to be replaced
because of intensifying drug resistance by more expensive
drugs. In an operational sense, a dipstick in the second
and third trimester may identify women in whom antima-
larial interventions failed and who are at increased risk of
maternal and foetal morbidity.
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